MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Primary membranous nephropathy (PMN), is an autoimmune glomerular disease and the main reason of nephrotic syndrome in adults. Studies have confirmed that the incidence of PMN increases yearly and is related to fine air pollutants particulate matter 2.5 (PM2.5) exposure. These imply that PM2.5 may b...

Full description

Bibliographic Details
Main Authors: Xiaoshan Zhou, Haoran Dai, Hanxue Jiang, Hongliang Rui, Wenbin Liu, Zhaocheng Dong, Na Zhang, Qihan Zhao, Zhendong Feng, Yuehong Hu, Fanyu Hou, Yang Zheng, Baoli Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.968256/full
_version_ 1797893967723888640
author Xiaoshan Zhou
Xiaoshan Zhou
Haoran Dai
Hanxue Jiang
Hongliang Rui
Hongliang Rui
Wenbin Liu
Zhaocheng Dong
Na Zhang
Qihan Zhao
Qihan Zhao
Zhendong Feng
Yuehong Hu
Yuehong Hu
Fanyu Hou
Yang Zheng
Baoli Liu
Baoli Liu
author_facet Xiaoshan Zhou
Xiaoshan Zhou
Haoran Dai
Hanxue Jiang
Hongliang Rui
Hongliang Rui
Wenbin Liu
Zhaocheng Dong
Na Zhang
Qihan Zhao
Qihan Zhao
Zhendong Feng
Yuehong Hu
Yuehong Hu
Fanyu Hou
Yang Zheng
Baoli Liu
Baoli Liu
author_sort Xiaoshan Zhou
collection DOAJ
description Primary membranous nephropathy (PMN), is an autoimmune glomerular disease and the main reason of nephrotic syndrome in adults. Studies have confirmed that the incidence of PMN increases yearly and is related to fine air pollutants particulate matter 2.5 (PM2.5) exposure. These imply that PM2.5 may be associated with exposure to PMN-specific autoantigens, such as the M-type receptor for secretory phospholipase A2 (PLA2R1). Emerging evidence indicates that Th17/Treg turns to imbalance under PM2.5 exposure, but the molecular mechanism of this process in PMN has not been elucidated. As an important indicator of immune activity in multiple diseases, Th17/Treg immune balance is sensitive to antigens and cellular microenvironment changes. These immune pathways play an essential role in the disease progression of PMN. Also, microRNAs (miRNAs) are susceptible to external environmental stimulation and play link role between the environment and immunity. The contribution of PM2.5 to PMN may induce Th17/Treg imbalance through miRNAs and then produce epigenetic affection. We summarize the pathways by which PM2.5 interferes with Th17/Treg immune balance and attempt to explore the intermediary roles of miRNAs, with a particular focus on the changes in PMN. Meanwhile, the mechanism of PM2.5 promoting PLA2R1 exposure is discussed. This review aims to clarify the potential mechanism of PM2.5 on the pathogenesis and progression of PMN and provide new insights for the prevention and treatment of the disease.
first_indexed 2024-04-10T07:02:23Z
format Article
id doaj.art-1468adb0279b42edbdc591854dadbdf8
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-10T07:02:23Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-1468adb0279b42edbdc591854dadbdf82023-02-27T16:52:37ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.968256968256MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathyXiaoshan Zhou0Xiaoshan Zhou1Haoran Dai2Hanxue Jiang3Hongliang Rui4Hongliang Rui5Wenbin Liu6Zhaocheng Dong7Na Zhang8Qihan Zhao9Qihan Zhao10Zhendong Feng11Yuehong Hu12Yuehong Hu13Fanyu Hou14Yang Zheng15Baoli Liu16Baoli Liu17Beijing University of Chinese Medicine, Beijing, ChinaBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, ChinaShunyi Branch, Beijing Hospital of Traditional Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaBeijing Institute of Chinese Medicine, Beijing, ChinaSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, ChinaBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, ChinaSchool of Traditional Chinese Medicine, Capital Medical University, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaSchool of Traditional Chinese Medicine, Capital Medical University, Beijing, ChinaPinggu Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaSchool of Traditional Chinese Medicine, Capital Medical University, Beijing, ChinaSchool of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, ChinaBeijing University of Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaShunyi Branch, Beijing Hospital of Traditional Chinese Medicine, Beijing, ChinaPrimary membranous nephropathy (PMN), is an autoimmune glomerular disease and the main reason of nephrotic syndrome in adults. Studies have confirmed that the incidence of PMN increases yearly and is related to fine air pollutants particulate matter 2.5 (PM2.5) exposure. These imply that PM2.5 may be associated with exposure to PMN-specific autoantigens, such as the M-type receptor for secretory phospholipase A2 (PLA2R1). Emerging evidence indicates that Th17/Treg turns to imbalance under PM2.5 exposure, but the molecular mechanism of this process in PMN has not been elucidated. As an important indicator of immune activity in multiple diseases, Th17/Treg immune balance is sensitive to antigens and cellular microenvironment changes. These immune pathways play an essential role in the disease progression of PMN. Also, microRNAs (miRNAs) are susceptible to external environmental stimulation and play link role between the environment and immunity. The contribution of PM2.5 to PMN may induce Th17/Treg imbalance through miRNAs and then produce epigenetic affection. We summarize the pathways by which PM2.5 interferes with Th17/Treg immune balance and attempt to explore the intermediary roles of miRNAs, with a particular focus on the changes in PMN. Meanwhile, the mechanism of PM2.5 promoting PLA2R1 exposure is discussed. This review aims to clarify the potential mechanism of PM2.5 on the pathogenesis and progression of PMN and provide new insights for the prevention and treatment of the disease.https://www.frontiersin.org/articles/10.3389/fphar.2022.968256/fullPM2.5PLA2R1microRNATh17/Tregprimary membranous nephropathy (PMN)
spellingShingle Xiaoshan Zhou
Xiaoshan Zhou
Haoran Dai
Hanxue Jiang
Hongliang Rui
Hongliang Rui
Wenbin Liu
Zhaocheng Dong
Na Zhang
Qihan Zhao
Qihan Zhao
Zhendong Feng
Yuehong Hu
Yuehong Hu
Fanyu Hou
Yang Zheng
Baoli Liu
Baoli Liu
MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
Frontiers in Pharmacology
PM2.5
PLA2R1
microRNA
Th17/Treg
primary membranous nephropathy (PMN)
title MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_full MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_fullStr MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_full_unstemmed MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_short MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_sort micrornas potential mediators between particulate matter 2 5 and th17 treg immune disorder in primary membranous nephropathy
topic PM2.5
PLA2R1
microRNA
Th17/Treg
primary membranous nephropathy (PMN)
url https://www.frontiersin.org/articles/10.3389/fphar.2022.968256/full
work_keys_str_mv AT xiaoshanzhou micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT xiaoshanzhou micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT haorandai micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT hanxuejiang micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT hongliangrui micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT hongliangrui micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT wenbinliu micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT zhaochengdong micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT nazhang micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT qihanzhao micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT qihanzhao micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT zhendongfeng micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT yuehonghu micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT yuehonghu micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT fanyuhou micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT yangzheng micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT baoliliu micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT baoliliu micrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy